Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:59 PM
Ignite Modification Date:
2025-12-24 @ 5:59 PM
NCT ID:
NCT07085468
Eligibility Criteria:
Inclusion Criteria:
* Have a body mass index (BMI) within the range of 22 to 25 kilograms per square meter (kg/m2)
* Have had a stable body weight for 3 months prior to screening
Exclusion Criteria:
* Have type 1 diabetes, latent autoimmune diabetes in adults, or a history of ketoacidosis or hyperosmolar coma
* Have:
* type 2 diabetes and on antidiabetic therapy (except type 2 diabetes being managed with diet and/or stable dose of metformin)
* rare forms of diabetes mellitus, or
* hemoglobin A1c (HbA1c) \>8%
* Have poorly controlled hypertension
* Have any of the following cardiovascular conditions within 12 months prior to screening:
* acute myocardial infarction
* stroke
* unstable angina, or
* hospitalization due to congestive heart failure.
* Have a history of New York Heart Association Functional Classification III or IV congestive heart failure
* Have signs and symptoms of liver disease
* Have a history of pancreatitis
* Have taken medications or alternative remedies for weight loss or weight gain within 3 months prior to screening
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
55 Years
Maximum Age:
80 Years
Study:
NCT07085468
Study Brief:
Protocol Section:
NCT07085468